Geraldine McFarlane

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1:  Design, Synthesis, and Preclinical Characterization

Hassan Elokdah, Magid Abou‐Gharbia, James K. Hennan et al. · Journal of Medicinal Chemistry · 2004 · 166 citations · Full text

Pharmaceutical Science, Antiparasitic Agent, Cardiovascular Pharmacology +20

Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 2. Selective and Potent Benzylamino Cyclobutenediones

A. Gilbert, Madelene Antane, Thomas M. Argentieri et al. · Journal of Medicinal Chemistry · 2000 · 53 citations

Vitro Potency, Potassium Channel Openers, Medicinal Chemistry +12

Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties

Hassan Elokdah, Theodore S. Sulkowski, Magid Abou‐Gharbia et al. · Journal of Medicinal Chemistry · 2003 · 45 citations

Substituted Sulfanyldihydroimidazolones, Pharmaceutical Science, Pharmacotherapy +18

Regioselective Suzuki coupling of benzofuran or benzothiophene boronic acids and dibromo substituted naphthalenes: synthesis of a potent inhibitor of plasminogen activator inhibitor-1

Zheng Wang, Hassan Elokdah, Geraldine McFarlane et al. · Tetrahedron Letters · 2006 · 30 citations

Medicinal Chemistry, Regioselective Suzuki Coupling, Plasminogen Activator Inhibitor-1 +5

Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia

David P. Rotella, Geraldine McFarlane, Alexander Greenfield et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 18 citations · Full text

Psychoactive Drug, Psychiatry, Psychotic Disorder +14